Activities
Publications
01
Bujang, M.A., Lai, W.H., Ratnasingam, S., Tiong, X.T., Hon, Y.K., Yap, E.P.P., Jee, Y.Y.H., Ahmad, N.F.D., Kim, A.R.J., Husin, M. and Haniff, J., 2023. ‘Development of a Quality-of-Life Instrument to Measure Current Health Outcomes: Health-Related Quality of Life with Six Domains (HRQ-6D).’ Journal of Clinical Medicine, 12(8), p.2816.
02
Chow, H.B., Tan, S.S.N., Lai, W.H. and Fong, A.Y.Y., 2023. ‘Angiography-derived fractional flow reserve in coronary assessment: Current developments and future perspectives.’ Cardiovascular Innovations and Applications, 8(1).
03
Bujang, M.A., 2023. ‘An elaboration on sample size planning for performing a one-sample sensitivity and specificity analysis by basing on calculations on a specified 95% confidence interval width.’ Diagnostics, 13(8), p.1390.
04
Hock, G.T., Teo, T.H., Bujang, M.A., Kiing, J.W. and Muniandy, P., 2023. ‘Prevalence of occupational hand eczema among healthcare workers and its associated risk factors in a tertiary hospital in Sarawak during COVID-19 pandemic.’ Indian Journal of Dermatology, 68(1), pp. 121.
05
Cham, Y.L., Fong, A.Y.Y., Chung, J.B.K., Ling, H.S., Pang, I.X., Thien, L.K., Chow, H.B., Chan, I.E.Z., Shu, F.E.P., Tan, C.T., Koh, K.T., Oon, Y.Y., Said, A. and Ong, T.K., 2023. ‘The novel biomarker growth differentiation factor-15 in patients with chronic heart failure at a heart failure clinic in the Asia-Pacific region: A prospective observational study.’ Journal of Asian Pacific Society of Cardiology, 2, p.e14.
06
Chow, H.B., Lim, C.T., Ho, Y.H., Cham, Y.L., Fong, A.Y.Y., Said, A. and Ong, T.K., 2023. ‘Pseudo-infarction electrocardiographic changes in delayed onset hypoparathyroidism: A case report.’ Clinical Case Reports, 11, p.e7580.
07
Peffault de Latour, R., Han, B., Maciejewski, J., Ueda, Y., Fu, R., Zhang, L., Kulasekararaj, A., Röth, A., Chew, L.P., Jang, J.H., Wong Lee, L., Panse, J., Yap, E.S., Marano, L., Sicre de Fontbrune, F., Yang, C., Banerjee, P., Wang, Z., Thorburn, C., Shujie, L., Dahlke, M. and Risitano, A., 2023. ‘Substantial increases in paroxysmal nocturnal hemoglobinuria (PNH) red blood cell clone size with oral iptacopan monotherapy confirms control of hemolysis in complement inhibitor-naïve PNH patients.’ Leukemia & Related Malignancies Myelodysplastic Neoplasms, 23(Supplement 1), p.S185.
08
Kremyanskaya, M., Chew, L.P., Rudraraju, S., Gupta, S. and Modi, N., 2023. ‘Pharmacokinetic and pharmacodynamic effects of rusfertide in polycythemia vera: Results from an ongoing phase 2 study in patients with elevated hematocrit values.’ Hemasphere, 7(Suppl), p.e685174d.
09
Ong Tang, A.S., Ko, C.T., Saari, Z., Selvaratnam, V., Chew, L.P. and Sathar, J., 2023. ‘Efficacy of reduced-dose emicizumab in hemophilia A with inhibitors: Real-world experience in Malaysia.’ Hemasphere, 7(Suppl), p.e269464e.
10
Tang, A., Leong, T.S., Wong, Q.Y., Tan, X.Y., Ko, C.T., Ngew, K.Y., The, E.K.J. and Chew, L.P., 2023. ‘The Sarawak Myelofibrosis (SaMy) experience: Demographics and outcome of myelofibrosis patients in Sarawak, Malaysia.’ SAGE Open Medicine, 11.
11
Yeo, J.J.P., Yeo, L.S., Tan, S.S.N., Delailah, D.D.R.A., Lee, S.W.H., Hu, A.T.H., Foo, D.H.P., Sahiran, F., Yap, I.K.S. and Fong, A.Y.Y., 2023. ‘Prevalence of true resistant hypertension in those referred for uncontrolled hypertension in Malaysia: A comparison using different definitions.’ Hypertension Research, 6 September. doi: 10.1038/s41440-023-01418-4.
12
Tan, M.H.P., Ong, S.C., Bujang, M.A. et al., 2023. ‘Evaluation of the health-related quality of life of patients with type 2 diabetes in relation to macro vascular and microvascular complications.’ Acta Diabetologica. Available at: https://doi.org/10.1007/s00592-023-02164-2.
13
Tan, S.H., King, T.L., Tan, S.S.N., Lai, W.H., Bujang, M.A. and Voon, P.J., 2023. ‘Development and validation of Join Clinical Trial Questionnaire (JoinCT).’ Asia-Pacific Journal of Clinical Oncology, 9 November. doi: 10.1111/ajco.14034.
14
Kho, S.S., Tan, S.H., Chai, C.S., Ngu, N.H., Yong, M.C., Chan, S.K. and Tie, S.T., 2023. ‘Performance of radial endobronchial ultrasound for peripheral pulmonary lesions without automation technology in a tuberculous endemic region: Real-world experience in a single institution over 6 years.‘ Journal of Thoracic Disease, 15(11), 30 November.
15
Kuo, K.H.M., Sutcharitchan, P., Bee, P.C., Chew, L.P. et al., 2023. ‘Efficacy and safety of luspatercept in patients with HbE/β-thalassemia from the BELIEVE study: A subgroup analysis.’ Blood, 142(Supplement 1), p.3848.
16
Prandoni, P., Haas, S., Fluharty, M.E. et al., 2023. ‘Incidence and predictors of post-thrombotic syndrome in patients with proximal DVT in a real-world setting: Findings from the GARFIELD VTE registry.’ Journal of Thrombosis and Thrombolysis. Available at: https://doi.org/10.1007/s11239-023-02895-7.
17
Tan, X.W., Fong, A.Y.Y. and Hwang, S.S., 2023. ‘Telomere and telomerase biology in cardiovascular disease: A state-of-the-art review and outlook.’ Journal of Asian Pacific Society of Cardiology, 2, p.e46.
19
Lee, J.W., Griffin, M., Kim, J.S. et al. and the ALXN2040-PNH-301 Investigators, 2023. ‘Addition of danicopan to ravulizumab or eculizumab in patients with paroxysmal nocturnal haemoglobinuria and clinically significant extravascular haemolysis (ALPHA): A double-blind, randomised, phase 3 trial.’ Lancet Haematology, 10(12), pp. e955-e965.
20
Jean, T.Y., Tatt, L.W., Wei, L.S., Kiong, S.C. and Bujang, M.A., 2023. ‘Morphology of mandibular condyle in the population of Sarawak: A retrospective cross-sectional study using digital panoramic radiograph.’ Malaysian Journal of Medical and Health Sciences, 19(4), pp. 258-264.
01
Lim, S. C. L. et al. (2022) ‘Efficacy of ivermectin treatment on disease progression among adults with mild to moderate COVID-19 and comorbidities: The I-TECH randomized clinical trial’, JAMA Internal Medicine, 182(4), pp. 426–435.
02
Sim, R. et al. (2022) ‘Comparative effectiveness of cardiovascular, renal and safety outcomes of second-line antidiabetic drugs use in people with Type 2 diabetes: A systematic review and network meta-analysis of randomised controlled trials, Diabetic Medicine: A Journal of the British Diabetic Association’, 39(3), p. e14780.
03
Yap, Y. Y., Sathar, J. and Law, K. B. (2022) ‘Mortality outcomes and survival patterns of patients with myeloproliferative neoplasms in Malaysia’, Cancer Causes & Control, 33(2), 343–351.
04
Lim, C. T. et al. (2022) ‘A descriptive study on characteristics of patients with myocardial infarction and their outcomes: A rural primary healthcare setting in Lubok Antu District, Sarawak’, Journal of Cardiovascular, Neurovascular & Stroke. Available at: https://mycvns.com.
05
WHO Solidarity Trial Consortium. (2022) ‘Remdesivir and three other drugs for hospitalised patients with COVID-19: Final results of the WHO Solidarity randomised trial and updated meta-analyses’, Lancet (London, England), 399(10339), pp. 1941–1953.
06
Tan, S. S. N. et al. (2022) ‘NT-proBNP cut-off values for risk stratification in acute MI and comparison with other risk assessment scores’, Journal of Asian Pacific Society of Cardiology, 1, p. e10.
07
Lai, W. H. et al. (2022) ‘Dementia of the ageing population in Malaysia: A scoping review of published research’, Aging and Health Research, 2(2), p. 100077.
08
Sia, C. H. et al. (2022) ‘Enhanced thrombin generation is associated with worse left ventricular scarring after ST-segment elevation myocardial infarction: A cohort study’, Pharmaceuticals, 15, p. 718.
09
Ab Rahman, N. et al. (2022) ‘Risk of serious adverse events after the BNT162b2, CoronaVac, and ChAdOx1 vaccines in Malaysia: A self-controlled case series study’, Vaccine, 40(32), pp. 4394-4402.
10
Wahab, S. et al. (2022) ‘Suicidal behaviour among elderly inpatient: Its relation to functional disability and pain’, Psychology Research and Behaviour Management, 15, pp. 737–750.
01
Tang, A. S. O. et al. (2021) ‘Demographics and outcome of patients with congenital haemophilia in Sarawak, Malaysia’, The Medical journal of Malaysia, 76(1), pp. 51–55.
02
Tang, A. S. O. et al. (2021) ‘Successful non-surgical treatment of an acute calculous cholecystitis in a myeloma patient with COVID-19: Case report’, SN Comprehensive Clinical Medicine, 3(2), pp. 666-669.
03
Tang, A. S. O. et al. (2021) ‘Immunodeficiency and thymoma: A case report on good syndrome, a diagnosis frequently missed and forgotten’, The American Journal of Case Reports, 22, pp. e928659-1-e928659-5.
04
Koh, K. T. et al. (2021) ‘Smartphone electrocardiogram for detecting atrial fibrillation after a cerebral ischaemic event: A multicentre randomized controlled trial’, Europace, 23(7), pp. 1016-1023.
05
Lee, C. Y. et al. (2021) ‘Sex and gender differences in presentation, treatment and outcome in acute coronary syndrome, a 10-year study from a multi-ethnic Asian population: The Malaysian NCVD-ACS Registry’, PLoS ONE, 16(2), p. e0246474.
06
Yingchoncharoen, T. et al. (2021) ‘Economic burden of heart failure in Asian countries with different healthcare systems’, Korean Circulation Journal, 51(8), pp. 681–693.
07
Tang, A. S. O. et al. (2021) ‘Challenges in managing a lepromatous leprosy patient complicated with melioidosis infection, dapsone-induced methemoglobinemia, haemolytic anaemia and lepra reaction’, The American Journal of Case Reports, 22, p. e931655.
08
Tang, A. S. O. et al. (2021) ‘First 2 fabry cases with novel mutation and their associated clusters in Malaysia’, The American Journal of Case Reports, 22, p. e932923.
09
Tang, A. S. O. et al. (2021) ‘The mystery of ‘saturation gap’ and falsely normal G6PD: A case of primaquine-induced haemolysis in plasmodium vivax malaria infection’, The Journal of the Royal College of Physicians of Edinburgh, 51(2), pp. 146–148.
10
Mohd Nor, S. R. et al. (2021) ‘Factors influencing nurses’ participation in clinical research: A cross-sectional survey in Hospital Putrajaya, Malaysia’, The Malaysian Journal of Nursing, 12(4).
11
Bujang, M. A. et al. (2021) ‘Quality of life and its associated factors among Type 2 diabetes patients in Malaysia primary health care’, International Medical Journal, 28(2), pp. 197-201.
12
Bujang, M. A. (2021) ‘A step-by-step process on sample size determination for medical research’, The Malaysian Journal of Medical Sciences, 28(2), pp. 15-27.
13
Subramaniam, S. et al. (2021) ‘Baseline cardiovascular comorbidities, and the influence on cancer treatment decision-making in women with breast cancer’, Ecancermedicalscience, 15, p. 1293.
14
Lee, S. E. et al. (2021) ‘Prevalence of atopic dermatitis among primary school children and its impact on quality of life in Kuching, Sarawak’, The Malaysian Journal of Dermatology, 46, pp. 21-46.
15
Kamarozaman, D. M. S. et al. (2021) ‘Situation analysis of fake braces among teenagers in Manjung District, Perak’, Malaysian Dental Journal, 1, pp. 61-83.
16
Chow, L. C. et al. (2021) ‘A family of three with haemoglobin cheverly: Low oxygen saturation in stable patients’, The Journal of the Royal College of Physicians of Edinburgh, 51(3), pp. 253-256.
17
Lin, Y. Y. et al. (2021) ‘Abstract 9497: Dose reduction of ticagrelor in ticagrelor hyper-responders: A pharmacokinetics and pharmacodynamics (PKPD) study’, Circulation, 144(1), p. A9497.
18
Koh, G. S. et al. (2021) ‘Ratio of nitric oxide metabolite levels in cerebrospinal fluid and serum, and their correlation with severity and outcome in patients with subarachnoid haemorrhage’, The Malaysian Journal of Medical Sciences, 28(6), pp. 42-54.
01
Cappellini, M. D. et al. (2020) ‘A phase 3 trial of luspatercept in patients with transfusion-dependent β-thalassemia’, The New England Journal of Medicine, 382(13), pp. 1219–1231.
02
Tang, A. S. O. et al. (2020) ‘Emicizumab in the management of haemophilia: A real world experience in Malaysia’, Haemophilia, 26(4), p. 29.
03
Lal, A. et al. (2020) ‘A hepcidin mimetic, ptg-300, demonstrates pharmacodynamics effects indicating reduced iron availability in transfusion-dependent beta-thalassemia subjects’, EHA Library. Available at: https://library.ehaweb.org/eha/2020/eha25th/295117/ashutosh.lal.a.hepcidin.mimetic.ptg-300.demonstrates.pharmacodynamic.effects
04
King, T. L. et al. (2020) ‘A hospital-based study on ischaemic stroke characteristics, management, and outcomes in Sarawak: Where do we stand?’, Journal of Stroke and Cerebrovascular Disease, 29(9).
05
Tern, P. J. W. et al. (2020) ‘Comparative overview of ST-Elevation myocardial infarction (STEMI) epidemiology, demographics, management and outcomes in 5 Asia-Pacific countries – A meta-analysis’, European Heart Journal – Quality of Care and Clinical Outcomes, 7(1), pp. 6-17.
06
Li, J. J. et al. (2020) ‘Statin intolerance: An updated, narrative review mainly focusing on muscle adverse effects’, Expert Opinion on Drug Metabolism & Toxicology, 16(9), pp. 837-851.
07
Hong, L. W. et al. (2020) ‘Channa striatus effectiveness in wound-healing: A scoping review’, International Journal of Research and Analytical Reviews, 7(1), pp. 300-308.
08
Lim, T. O. T. et al. (2020) ‘Cascade of care, awareness and treatment of chronic hepatitis B in Malaysia-findings from a community-based screening campaign’, medRxiv. doi:10.1101/2020.06.15.20131409
09
Zainal, Z. et al. (2020) ‘Quality improvement of postgraduate medical protocol (PMP) submitted to national medical research registry (NMRR), Malaysia’, Quantum Journal of Social Sciences and Humanities, 1(1), pp. 1-11.
10
Foo, D. H. P. et al. (2020) ‘COVID-19 testing strategy in response to infection among healthcare workers in a large non-COVID-designated hospital’, Hospital Practice. doi:10.1080/21548331.2020.1857999
11
Chow, L. C. et al. (2020) ‘Thrombosis and bleeding as presentation of COVID-19 infection with polycythemia vera: A case report’, SN Comprehensive Clinical Medicine, pp. 1-5.
12
Chan, M. Y. et al. (2020) ‘Prioritizing candidates of post–myocardial infarction heart failure using plasma proteomics and single-cell transcriptomics’, Circulation, 142, pp. 1408–1421.
13
Jian, J. L. et al. (2020) ‘Tackling cardio-metabolic risk in the Asia Pacific region’, American Journal of Preventive Cardiology, 4, p. 100096.
14
Foo, D. H. P. et al. (2020) ‘Imaging criteria by echocardiography for detection of hypertrophic cardiomyopathy in elite athletes’, AHJ, 27(2), pp. 10-16.
15
Ling, H. S. et al. (2020) ‘Acute decompensated heart failure in a non-cardiology tertiary referral center, Sarawak General Hospital (SGH-HF)’, BMC Cardiovascular Disorders, 20(1), p. 511.
01
Tan, S. Y. et al. (2019) ‘Pre-operative predictive factors influencing mortality after tracheostomy (TRACHMORT)’, International Medical Journal, 26(1), pp. 34–38.
02
Lim, A. W. et al. (2016) ‘Comparison of intravenous fluid regimens in managing dengue patients by evaluating hematocrit levels and hemodynamic parameters’, International Medical Journal, 26(1), pp. 9–12.
03
Tang, A. S. O. et al. (2019) ‘The mystery of ‘saturation gap’: A case of dapsone-induced methaemoglobinemia in a pregnant mother with leprosy’, Oxford Medical Case Reports, 1, pp. 8–10.
04
Tang, A. S. O. et al. (2019) ‘Cerebral venous thrombosis as an initial manifestation of acute myeloid leukemia’, Oxford Medical Case Reports, 1, pp. 32–34.
05
Ting, C. Y. et al. (2019) ‘Pilot study on functional performance and acceptability of two new synthetic adhesive male condoms (Wondaleaf): A randomized cross-over trial’, Contraception, 100(1), pp. 65-71.
06
Bujang, M. A. et al. (2019) ‘Risk factors for 3-year-mortality and a tool to screen patient in dialysis population’, Indian Journal of Nephrology, 29(4), pp. 235–241.
07
Lau, E. T. L. et al. (2019) ‘Counselling interactions between patients living with persistent pain and pharmacists in Australia: Are we on the same page?’, Journal of Pain Research, 12, pp. 2441-2455.
08
Ting, C. Y. et al. (2019) ‘Heavy metals (Cr, Pb, Cd, Ni) in aerosols emitted from electronic cigarettes sold in Malaysia’, Journal of Environmental Science and Health, 55(1), pp. 55-62.
09
Yeo, L. S. et al. (2019) ‘Survey of public knowledge, perception and consequent attitudes towards clinical research among participants of UNIMAS clinical trial awareness campaign’, Sarawak Health Journal, 6(10).
10
Ting, C. Y. et al. (2019) ‘Heavy metals emitted from cigarettes aerosol: Evidence from the state of Sarawak, Malaysia’, Sarawak Health Journal, 6(20).
11
Leong, T. S. et al. (2019) ‘Treatment outcome and a practical 10-point prognostic index in adult patients with non-M3 acute myeloid leukaemia: A retrospective, multicentre study in Malaysia’, Blood, The Journal of the American Society of Haematology, 134(1), p. 2606.
12
Ahrens, I. et al. (2019) ‘Invasive and antiplatelet treatment of patients with non-ST-segment elevation myocardial infarction: Understanding and addressing the global risk-treatment paradox’, Clinical Cardiology, 42(10), pp. 1028-1040.
13
Her, A. Y. et al. (2019) ‘Drug-coated balloon treatment in coronary artery disease: Recommendations from an Asia-Pacific Consensus Group’, Cardiology Journal, 28(1), pp. 136-149.
14
Lee, Y. F. et al. (2019). ‘Hand hygiene – social network analysis of peer-identified and management selected change agents’, Antimicrobial Resistance and Infection Control, 8(195), pp. 1-7.
15
Ryan, D. H. et al. (2019) ‘Results of a phase 3, randomized, double-blind, placebo- controlled study of luspatercept in adult beta-thalassemia patients who require regular red blood cell transfusion’, British Journal of Haematology, 185(1), p. 3-202. doi:10.1111\bjh.15854
16
Lee, J. W. et al. (2019) ‘Ravulizumab (ALXN1210) vs eculizumab in adult patients with PNH naive to complement inhibitors: The 301 study’, Blood, 133(6), pp. 530–539.
17
Bujang, M. A. et al. (2019) ‘The all-cause mortality and risk factors for mortality within five years among prevalent Type 1 Diabetes Mellitus Patients’, International Journal of Diabetes in Developing Countries, 39, pp. 284–290.
01
Lim, S. C. L. et al. (2022) ‘Efficacy of ivermectin treatment on disease progression among adults wita
01
Chuo, Y. T. et al. (2018) ‘Effectiveness and sustainability of a structure group-based educational program (MEDIHEALTH) in improving medication adherence among Malay patients with underlying Type 2 diabetes mellitus in Sarawak State of Malaysia: A study protocol of a randomized controlled trial’, Trials, 19, p. 310.
02
Hian, Y. V. et al. (2018) ‘Carbetocin versus oxytocin for the prevention of postpartum haemorrhage: A meta-analysis of randomized controlled trials in caesarean deliveries’, Taiwanese Journal of Obstetrics & Gynaecology, 57, pp. 332-339.
03
Tiong, X. T. et al. (2018) ‘Validation of the Kessler’s psychological distress (K10 & K6) in a Malaysian population’, Asian Journal of Psychology, 19(1).
04
Bujang, M. A. et al. (2018) ‘A revised version of diabetes quality of life instrument maintaining domains for satisfaction, impact and worry’, Journal of Diabetes Research. doi:10.1155/2018/5804687
05
Bujang, M. A. et al. (2018) ‘The all-cause mortality and a screening tool to determine high-risk patients among prevalent Type 2 diabetes mellitus patients’, Journal of Diabetes Research. doi:10.1155/2018/4638327.
h mild to moderate COVID-19 and comorbidities: The I-TECH randomized clinical trial’, JAMA Internal Medicine, 182(4), pp. 426–435.
02
Sim, R. et al. (2022) ‘Comparative effectiveness of cardiovascular, renal and safety outcomes of second-line antidiabetic drugs use in people with Type 2 diabetes: A systematic review and network meta-analysis of randomised controlled trials, Diabetic Medicine: A Journal of the British Diabetic Association’, 39(3), p. e14780.
03
Yap, Y. Y., Sathar, J. and Law, K. B. (2022) ‘Mortality outcomes and survival patterns of patients with myeloproliferative neoplasms in Malaysia’, Cancer Causes & Control, 33(2), 343–351.
04
Lim, C. T. et al. (2022) ‘A descriptive study on characteristics of patients with myocardial infarction and their outcomes: A rural primary healthcare setting in Lubok Antu District, Sarawak’, Journal of Cardiovascular, Neurovascular & Stroke. Available at: https://mycvns.com.
05
WHO Solidarity Trial Consortium. (2022) ‘Remdesivir and three other drugs for hospitalised patients with COVID-19: Final results of the WHO Solidarity randomised trial and updated meta-analyses’, Lancet (London, England), 399(10339), pp. 1941–1953.
06
Lau, S. M. et al. (2018) ‘Adult aedes mosquito and dengue virus surveillance in residential and public areas of Selangor Malaysia’, Southeast Asian Journal of Tropical Medicine and Public Health, 49(4).
07
Patmanathan, S. N. et al. (2018) ‘Crispr/Cas9 in stem cell research: Current application and future perspective’, Current Stem Cell Research and Therapy. doi: 10.2174/1574888X13666180613081443
08
Zakaria. Z. H., Fong, A. Y. Y. and Raj K. S. Badhan. (2018) ‘Clopidogrel pharmacokinetics in Malaysian population groups: The impact of inter-ethnic variability’, Pharmaceuticals, 11(74). doi:10.3390/ph11030074
09
de Carvalho, L. P. et al. (2018) ‘Plasma ceramides as prognostic biomarkers and their arterial and myocardial tissue correlates in acute myocardial infarction’, JACC: Basic to Translational Science, 3(2), pp. 163-175.
10
Rigatelli, G., Zuin, M. and Fong, A Y. Y. (2018) ‘Computational flow dynamic analysis of right and left atria in patent foramen ovale: Potential links with atrial fibrillation’, Journal of Atrial Fibrillation, 10(5), p. 1852
11
Tiong, X. T. et al. (2018) ‘The association of the dietary approach to stop hypertension (DASH) diet with blood pressure, glucose and lipid profiles in Malaysian and Philippines populations’, Nutrition, metabolism, and Cardiovascular Disease, 28(8), 856–863.
12
de Carvalho, L. P. et al. (2018) ‘Prognostic implications of dual platelet reactivity testing in acute coronary syndrome’, Thrombosis and Haemostasis, 118(2), pp. 415-426.
13
Tan, Y. F. et al. (2018) ‘Isolation and quantification of mimi virus-like and marseille virus-like viruses from soil samples in an aboriginal (Orang Asli) village in Peninsular Malaysia’, Intervirology. doi:10.1159/000491602
14
Yusof, M. R. K. J. et al. (2018) National Heart Association Malaysia (NHAM) Transthoracic Echocardiogram (TTE) Guide 2018. Kuala Lumpur: Malaysia.
15
Tan, C. S. Y. et al. (2018) ‘INR control of patients with mechanical heart valve on long-term warfarin therapy’, Global Heart, 13(4), pp. 241-244.
16
Chew, J. T. et al. (2018) ‘GW29-e0830 GLADIATER: An algorithm to support anomaly detection from a longitudinal cardiovascular and diabetes dataset, Journal of the American College of Cardiology, 72(16), pp. C244-5.
17
Tsai, H. O. N. et al. (2018) ‘Comparison of rivaroxaban concentrations between Asians and Caucasians and their correlation with PT/INR’, Journal of Thrombosis and Thrombolysis, 46, pp. 541-548.
18
Tan, S. S. N. et al. (2018) ‘Late stent thrombosis in a patient with CYP2C19 *3/*17 genotype and clopidogrel high on-treatment platelet reactivity’, Pharmacogenomics, 19(15), pp. 1151-1157.
19
Low, Y. M. et al. (2018) ‘Elucidating the survival and response of carbapenem resistant Klebsiella pneumonia after exposure to imipenem at sub-lethal concentrations’, Pathogens and Global Health, 112(7), pp. 378-386.
20
Chu, W. L. et al. (2018) ‘Heavy metal pollution in Antarctica and its potential impacts on algae’, Polar Science, 20(1), pp. 75-83.
21
Bujang, M. A. et al. (2018) ‘The all-cause mortality and risk factors for mortality within five years among prevalent Type 1 diabetes mellitus patients’, International Journal of Diabetes in Developing Countries, pp. 1-7.
22
Tang, A. S. O. et al. (2018) ‘Thrombotic thrombocytopenic purpura-like syndrome associated with arcanobacterium pyogenes endocarditis in a post-transplant patient: A case report’, The Medical journal of Malaysia, 73(5), p. 344.
23
Bujang, M. A. et al. (2018) ‘Sample size guidelines for logistic regression from observational studies with large population: Emphasis on the accuracy between statistics and parameters based on real life clinical data’, Malaysia Journal of Medical Sciences, 25(4), pp. 122-130.
24
Lim, C. J. et al. (2018) ‘Validation of Malay version of body self-image questionnaire-short form among Malaysian young adults’, Malaysia Journal of Medical Sciences, 25(4), pp. 131-141.
25
Bujang, M. A. and Sapri, F. E. (2018) ‘An application of the runs test to test for randomness of observations obtained from a clinical survey in an ordered population’, Malaysia Journal of Medical Sciences, 25(4), pp. 146-151.
26
Sebastian, Y. et al. (2018) ‘Anomaly detection from diabetes similarity graphs using community detection and Bayesian techniques’, Proceedings of the 12th International Conference on Ubiquitous Information Management and Communication, p. 32.
27
Tan, A. H. et al. (2018) ‘Altered gut microbiome and metabolome in patients with multiple system atrophy’, Movement Disorders, 33, pp. 174-176.
28
Bong, J. M. I. et al. (2018) ‘Handgrip strength and health-related quality of life in elderly patients attending physiotherapy clinics’, Asian Journal of Gerontology Geriatrics, 13(2). doi: 10.12809/ajgg-2018-295-oa
29
Yap, Y. Y. et al. (2018) ‘The epidemiology and clinical characteristics of myeloproliferative neoplasms in Malaysia’, Experimental Haematology & Oncology, 7(31). doi:10.1186/s40164-018-0124-7
01
Anchah, L. et al. (2017) ‘Health related quality of life assessment in acute coronary syndrome patients: The effectiveness of early phase 1 cardiac rehabilitation’, Health and Quality of Life Outcomes, 15(10), pp. 1-14.
02
Ruvandhi, R. N. et al. (2017) ‘Agents of change: The role of healthcare workers in the prevention of nosocomial and occupational tuberculosis’, Presse Med, 46, pp. 53-62.
03
Ganeshan, M. et al. (2017) ‘Importance of adopting BMI classifications using public health action points to delineate obstetric risk factors resulting in worsening obstetric outcomes among Asian population’, Journal of Obstetrics and Gynaecology of India, 68(3), pp. 173-178.
04
Bujang, M. A. and Baharum, N. (2017) ‘Guidelines of the minimum sample size requirements for Kappa agreement test’, Epidemiology, Biostatistics and Public Health, 14(2), pp. e122671-1.
05
Lee, K. Y. et al. (2017) ‘Cost of elective percutaneous coronary intervention in Malaysia: A multicentre cross-sectional costing study’, BMJ Open, 7, pp. e14307.
06
Tang, A. S. O. et al. (2017) ‘Subcutaneous mycosis presenting as a non-healing left calf ulcer in an immunocompromised patient’, Malaysia Journal of Medicine, 72(2), pp. 122-123.
07
Bujang, M. A. and Baharum, N. (2017) ‘A simplified guide to determination of sample size requirements for estimating the value of intraclass correlation coefficient: A review’, Archives of Orofacial Science – The Journal of the School of Dental Sciences USM, 12(1), pp. 1-11.
08
Ooi, C. H. et al. (2017) ‘Over two decades of Plasmodium Knowles infections in Sarawak: Trend and forecast’, Acta Tropica, 176, pp. 83-90.
09
Tan, S. S. N. et al. (2017) ‘Association of CYP2C19*2 polymorphism with clopidogrel response and 1-year major adverse cardiovascular events in a multi-ethnic population with drug-eluting stents’, Pharmacogenomics, 18(3), pp. 1225-1239.
10
Chin, H. H., Leong, T. S. and Chew, L. P. (2017) ‘May-hegglin anomaly with R1339X masquerading as idiopathic thrombocytopenic purpura and dengue fever (A presentation family)’, International Journal of Haematology Research, 3(1), pp. 1-3.
11
Abdullah, N. S. S et al. (2017) K10 scales (Malay version). Available at: http://www.hcp.med.harvard.edu /ncs/k6_scales.php
12
Chin, C. T. et al. (2017) ‘Characteristics and outcomes of medically managed patients with non-ST-segment elevation acute coronary syndromes: Insights from the multinational EPICOR Asia study’, International Journal of Cardiology, 243, pp. 15-20.
13
Lee, K. Y. et al. (2017) ‘Comparison of the treatment practice and hospitalization cost of percutaneous coronary intervention between a teaching hospital and a general hospital in Malaysia: A cross sectional study’, PLoS ONE, 12(9), pp. e0184410.
01
Dulguerova, F. et al. (2016) ‘Hypertrophic obstructive cardiomyopathy: The mitral valve could be the key’, European Journal of Cardiothoracic Surgery. Available at: https://ejcts.oxfordjournals.org/content/early/2016/01/19/ejcts.ezv473.abstract (Accessed: 16 January 2016).
02
Delft, A. V. et al. (2016) ‘Exposed, but not protected: more is needed to prevent drug-resistant tuberculosis in healthcare workers and students’, Clinical Infectious Disease, 62(3), pp. 275-280.
03
Chai, L. S., Putit, Z. and Siop, S. (2016) ‘Barriers to timely treatment-seeking in patients with acute myocardial infarction in Malaysia: A qualitative study’, BMC Nursing, 15, p. 33.
04
Chan, W. K. et al. (2016) ‘Procedure duration estimation and accuracy: A new key performance index?’, 3rd Sarawak Health Journal, p. 6.
05
Kuan, P. X., Chan., W. K. and Fong, A. Y. Y. (2016) ‘Physiotherapy in critically ill patients in Sarawak General Hospital’, 3rd Sarawak Health Journal, p. 8.
06
Tiong, X. T. and Fong, A. Y. Y. (2016) ‘A review of clinician-investigators at Sarawak General Hospital undertaking clinical research – industry of investigator initiated studies?’, 3rd Sarawak Health Journal, p. 20.
07
Lee, W. H., Leong, T. S. and Chew, L. P. (2016) ‘Endocrine disorder masquerading as blood malignancy: A case report’, 3rd Sarawak Health Journal, p. 39.
08
Leong, T. S., Lee, W. H. and Chew, L. P. (2016) ‘A rare disease encounter: Hitting hard may not be the answer’, 3rd Sarawak Health Journal, p. 44.
09
Leong, T. S., Lee, W. H. and Chew, L. P. (2016) ‘Does low platelet count equate to immune thrombocytopenic pupura?’, 3rd Sarawak Health Journal, p. 46.
10
Kuan, W. J. et al. (2016) ‘A pioneer experience in Malaysia on in-house radio labelling of (131)I-Rituximab in treatment of non-Hodgkin’s lymphoma and a case report of high dose (131)I-Rituximab–BEAM conditioning autologous transplant’, Applied Radiation and Isotope, 166, pp. 13-21.
11
Kuan, P. X. et al. (2016) ‘Variable clinical presentation of left atrial myxoma in Malaysia: A case series’, Journal of the Hong Kong College of Cardiology, 24(1), p. 36.
12
Hector, A. et al. (2016) ‘From basic mechanisms to clinical applications in heart protection, new players in cardiovascular diseases and cardiac theranostics: Meeting report from the third international symposium on “New frontiers in cardiovascular research”, Basic Research in Cardiology, 11(69), pp. 1-13.
13
The International Surgical Outcomes Study Group. (2016) ‘Global patient outcomes after elective surgery: Prospective cohort study in 27 low-, middle- and high-income countries’, British Journal of Anaesthesia, 117(5), pp. 601-609.
14
Kuan, P. X. et al. (2016) ‘Discrepancy in blood pressure between the left and right arms – importance of clinical diagnosis and role of radiological imaging’, Medical Journal of Malaysia, 71(4), pp. 206-208.
